[2] Zapatero A, Guerrero A, Maldonado X, et al. High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial. Lancet Oncol. 2015; 16: 320-7. [3] Dorff TB, Flaig TW, Tangen CM, et...
在欧洲患者亚组，与安慰剂 + ADT + 多西紫杉醇相比，达罗鲁胺 + ADT + 多西紫杉醇三联治疗改善了患者总生存率，死亡风险降低了37% (HR 0.63, 95% CI 0.48-0.83) ，4年生存率改善(61.6% VS 43.7%) ，与总体人群一致:与安慰剂 + ADT + 多西紫杉醇组相比，达罗他胺+ ADT + 多西紫杉醇组患者至...
[2]Casado E, Borque-Fernando A, Caamaño M, et al. Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy. The World Journal of Men's Health, 2022, 40(1): 74. [3]Gómez-Aparic...
6. Gu C, Wang Z, Lin T, et al. Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial. Chin Med J (Engl). 2023;136(10):1207-1215. doi:10.1097/CM9.0000000000002638 朱寅杰 ...
2023年11月02日,哥伦比亚大学爱尔文医学中心的研究人员在Cancer Cell期刊发表了题为:Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer的研究文章。与其他恶性肿瘤相比,原发性和去势抵抗性前列腺癌(CRPC)的肿瘤微环境(TME)...
Early ADT for prostate cancer fails to improve survivalAndrogen deprivation therapy provides no survival benefit in older men with localized prostate cancer at 15 years, newly published research shows.Study findings, from Rutgers Cancer Institute ofRichard R. Kerr...
[9]Maribel C , Barbara B , Chiara B M , et al. Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review. Physical Therapy. 声明 本视频/资讯/文章是由益普生医学团队编辑/医疗卫生专业人士撰写提供,...
[1] Spratt DE, George DJ, Shore ND, et al. Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer. JAMA Oncol. Published online March 07, 2024. doi:10.1001/jamaoncol.2023.7279 作者...
[1] Spratt DE, George DJ, Shore ND, et al. Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer. JAMA Oncol. Published online March 07, 2024. doi:10.1001/jamaoncol.2023.7279 作者:孙妮妮;编辑:Bree ...
Langley RE, et al. Transdermal oestradiol for androgen suppression in prostate cancer: long-termcardiovascularoutcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.Lancet. 2021 Feb 13;397(10274):581-591. ...